Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
- PMID: 8102388
- PMCID: PMC2191152
- DOI: 10.1084/jem.178.3.1041
Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells
Abstract
Natural killer cell stimulatory factor or interleukin 12 (NKSF/IL-12) is a heterodimeric cytokine produced by monocytes/macrophages, B cells, and possibly other accessory cell types primarily in response to bacteria or bacterial products. NKSF/IL-12 mediates pleiomorphic biological activity on T and NK cells and, alone or in synergy with other inducers, is a powerful stimulator of interferon gamma (IFN-gamma) production. IL-10 is a potent inhibitor of monocyte-macrophage activation, that inhibits production of tumor necrosis factor alpha (TNF-alpha), IL-1 and also IFN-gamma from lymphocytes acting at the level of accessory cells. Because TNF-alpha and IL-1 are not efficient inducers of IFN-gamma, the mechanism by which IL-10 inhibits IFN-gamma production is not clear. In this paper, we show that IL-10 is a potent inhibitor of NKSF/IL-12 production from human peripheral blood mononuclear cells activated with Staphylococcus aureus or lipopolysaccharide (LPS). Both the production of the free NKSF/IL-12 p40 chain and the biologically active p70 heterodimer are blocked by IL-10. NKSF/IL-12 p40 chain mRNA accumulation is strongly induced by S. aureus or LPS and downregulated by IL-10, whereas the p35 mRNA is constitutively expressed and only minimally regulated by S. aureus, LPS, or IL-10. Although IL-10 is able to block the production of NKSF/IL-12, a powerful inducer of IFN-gamma both in vitro and in vivo, the mechanism of inhibition of IFN-gamma by IL-10 cannot be explained only on the basis of inhibition of NKSF/IL-12 because IL-10 can partially inhibit IFN-gamma production induced by NKSF/IL-12, and also, the IFN-gamma production in response to various stimuli in the presence of neutralizing antibodies to NKSF/IL-12. Our findings that antibodies against NKSF/IL-12, TNF-alpha, or IL-1 beta can significantly inhibit IFN-gamma production in response to various stimuli and that NKSF/IL-12 and IL-1 beta can overcome the IL-10-mediated inhibition of IFN-gamma, suggest that IL-10 inhibition of IFN-gamma production is primarily due to its blocking production from accessory cells of the IFN-gamma-inducer NKSF/IL-12, as well as the costimulating molecule IL-1 beta.
Similar articles
-
Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.J Exp Med. 1992 Nov 1;176(5):1387-98. doi: 10.1084/jem.176.5.1387. J Exp Med. 1992. PMID: 1357073 Free PMC article.
-
Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation.Prog Growth Factor Res. 1992;4(4):355-68. doi: 10.1016/0955-2235(92)90016-b. Prog Growth Factor Res. 1992. PMID: 1364096 Review.
-
Differential regulation of interleukin-12 (IL-12), tumor necrosis factor alpha, and IL-1 beta production in human myeloid leukemia cell lines and peripheral blood mononuclear cells.Blood. 1994 Apr 1;83(7):1847-55. Blood. 1994. PMID: 7908232
-
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.J Exp Med. 1991 Apr 1;173(4):869-79. doi: 10.1084/jem.173.4.869. J Exp Med. 1991. PMID: 1672545 Free PMC article.
-
Immunoregulation by interleukin-12.J Leukoc Biol. 1996 Apr;59(4):505-11. doi: 10.1002/jlb.59.4.505. J Leukoc Biol. 1996. PMID: 8613697 Review.
Cited by
-
The Role of Proline-Proline-Glutamic Acid (PPE) Proteins in Mycobacterium tuberculosis Virulence: Mechanistic Insights and Therapeutic Implications.Cureus. 2024 Jan 9;16(1):e51955. doi: 10.7759/cureus.51955. eCollection 2024 Jan. Cureus. 2024. PMID: 38333477 Free PMC article. Review.
-
Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target.Front Cell Dev Biol. 2024 Jan 9;11:1332205. doi: 10.3389/fcell.2023.1332205. eCollection 2023. Front Cell Dev Biol. 2024. PMID: 38264357 Free PMC article. Review.
-
Genetic perspectives on the influence of circulating cytokines on acne: A Mendelian randomization study.Medicine (Baltimore). 2023 Dec 15;102(50):e36639. doi: 10.1097/MD.0000000000036639. Medicine (Baltimore). 2023. PMID: 38115273 Free PMC article.
-
Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer.Front Immunol. 2023 Oct 31;14:1274431. doi: 10.3389/fimmu.2023.1274431. eCollection 2023. Front Immunol. 2023. PMID: 38022654 Free PMC article.
-
Molecular Characterization and Expression Analysis of IL-10 and IL-6 in Channel Catfish (Ictalurus punctatus).Pathogens. 2023 Jun 29;12(7):886. doi: 10.3390/pathogens12070886. Pathogens. 2023. PMID: 37513733 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
